AEVS.SW
SellHot AirAevis Victoria SA · Healthcare · Switzerland · $1.4B · Avg Vol: $1M/d
Hot Air: Rising on momentum alone: weak business, rich price.
34
StockRankGet insider-trade alerts
QualityQuality
35
ValueValue
27
MomentumMomentum
62
P/E (TTM)
—
peers 29.9x
ROE
-4.5%
peers 11.1%
D/E
1.7x
peers 0.4x
Dividend %
—
trailing yield
Director trades · 180d
−$22.6M →
sold by directors
Subst. holders: +$4.9M · −$4.9M
Buybacks · 180d
None →
ABOUT AEVIS VICTORIA SA
Read
Aevis Victoria SA engages in the healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. It operates through Hospitals, Hospitality, and Real Estate segments.
FINANCIAL SUMMARY (CHF)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.1B | 952.9M | 1.0B | 1.2B | 3.2% | 1.0B | 1.2B | 1.2B | 1.8% |
| EPS (CHF) | -0.05 | 0.70 | -0.47 | -0.03 | -0.24 | — | -0.23 | — | — | — |
| Shares | — | 84.4M | 84.3M | 84.1M | 84.4M | +0.0% | 86.4M | — | — | — |
| Debt | — | 970.0M | 1.0B | 1.1B | 949.8M | -0.7% | 946.3M | — | — | — |
| Equity | — | 469.3M | 491.9M | 530.9M | 509.8M | 2.8% | — | — | — | — |
| Op CF | — | 114.3M | 42.7M | 46.5M | 72.6M | -14.1% | 72.3M | — | — | — |
| Inv CF | — | -56.7M | 35.6M | -62.3M | 56.0M | — | — | — | — | — |
| Fin CF | — | -45.5M | -73.0M | -28.1M | -136.5M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+13.8%
SMA 50SMA 200
Close
$18.01
RSI (14)
76.7
52W High
$18.13
From 52W High
1.0%
SCORE BREAKDOWN
Quality
35
ROIC
0.6%45.2
ROE
-4.5%39.2
GP/Assets
13.4%32.0
Op. Margin
-4.8%30.5
FCF/Assets
0.3%46.2
Piotroski
549.1
Int. Cover
0.3x36.6
D/E Ratio
1.72x6.7
Current Ratio
0.67x3.9
Value
27
P/E (TTM)
—N/A
EV/EBITDA
47.6x12.1
P/FCF
225.3x6.1
P/B
2.6x50.8
P/S
1.3x78.0
Div Yield
—N/A
Momentum
62
52W High %
99%99.1
RS 6M
2%65.6
SMA 50/200
0.98x50.6
EPS Rev 4W
-11.4%6.2
EPS Rev 12W
—N/A
EPS Improve
+216%88.3
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$1.4B
P/E (Forward)
59.3x
Gross Margin
25.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AEVS.SW are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AEVS.SW | Aevis Victoria SA(you) | $1.4B | 34 | Sell |
| MED.SW | Medartis Holding AG | $1.4B | 39 | Hold |
| KURN.SW | Kuros Biosciences AG | $1.0B | 33 | Sell |
| SOPH | SOPHiA GENETICS SA | $693M | 33 | Sell |
| NVCR | NovoCure Limited | $2.1B | 40 | Hold |
| IDIA.SW | Idorsia Ltd | $1.7B | 22 | Sell |
| MOVE.SW | Medacta Group SA | $3.1B | 39 | Hold |
| PPGN.SW | PolyPeptide Group AG | $1.8B | 51 | Hold |
| PHVS | Pharvaris N.V. | $2.5B | 21 | Sell |
| MLTX | MoonLake Immunotherapeutics | $1.3B | 8 | Strong Sell |
Peer medians: ROE 11.1% · P/E 29.9x · Gross margin 62.5%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.